Marina Hahn Source Confirmed

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

John Brown University

faculty

5 h-index 19 pubs 187 cited

Is this your profile? Verify and claim your profile

Biography and Research Information

OverviewAI-generated summary

Dr. Marina Hahn's work at John Brown University encompasses cancer research with a focus on glioma diagnosis and treatment. Her investigations extend to cell death mechanisms, the effects of radiation exposure, and laser-plasma interactions. Hahn's research explores therapeutic strategies targeting TRAIL death receptors and the efficacy of imipridone-based triple therapies in reducing intracranial tumor burden in glioblastoma models. She has also investigated the potential of TRAIL agonists in rescuing mice from radiation-induced injuries affecting the lungs, skin, and esophagus. Hahn's work also studies the combined effects of ONC201 with temozolomide and radiotherapy against glioblastomas. Her research efforts are centered on cancer, hypoxia, and metabolism.

Metrics

  • h-index: 5
  • Publications: 19
  • Citations: 187

Selected Publications

  • Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy reduces intracranial tumor burden, prolongs survival in orthotopic IDH-WT GBM mouse model, and suppresses MGMT (2025) DOI

Collaborators

Researchers in the database who share publications

Similar Researchers

Based on overlapping research topics